News for WPD Pharmaceuticals Inc. (WBIO.CN)

WPD ANNOUNCES SETTLEMENT OF DEBT FOR COMMON SHARES VANCOUVER, British Columbia, June 6, 2024 - WPD Pharmaceuticals Inc. is pleased to...

WPD Receives Full Revocation of Cease Trade Order VANCOUVER, British Columbia, May 16, 2024 - WPD Pharmaceuticals Inc. is excited to...

WPD's Polish Subsidiary Signs Investment Agreement with ACRX Investments Limited VANCOUVER, British Columbia, September 1, 2023 - WPD...

WPD Pharmaceuticals Announces Closing of Convertible Debenture Private Placement VANCOUVER, British Columbia, June 15, 2023 - WPD Pharmaceuticals Inc. ... | June 16, 2023

PRLog - Global Press Release Distribution WPD Pharmaceuticals Provides A Corporate Update VANCOUVER, British Columbia... | November 18, 2022

Read Head-To-Head Survey: CNS Pharmaceuticals (NASDAQ:CNSP) vs. Corcept Therapeutics (NASDAQ:CORT) at ETF Daily News

VANCOUVER, British Columbia, May 16, 2022 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage...

Expert research team aiming to optimize the effects of radiotherapy of brain tumors...

VANCOUVER, British Columbia, Feb. 09, 2022 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (the “Company” or “WPD”) (CSE: WBIO) (FSE: 8SV1) announces that...

VANCOUVER, British Columbia, Feb. 03, 2022 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (the “Company” or “WPD”) (CSE: WBIO) (FSE: 8SV1), is pleased to...

VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals (CSE:WBIO) (8SV1.F) ("WPD" or the "Company") today announced that ...

WPD Pharmaceuticals plans to initiate a Berubicin Phase 2 adult GBM trial in the first half of 2021 and a multicenter pediatric malignant glioma P...

VANCOUVER, British Columbia, Jan. 14, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE:WBIO)(FSE: 8SV1) (the "Company" or "WPD") a clinical-stage ...